Panagora Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,165
| Closed | -$20K | – | 3121 |
|
|
2020
Q3 | $20K | Hold |
2,165
| – | – | ﹤0.01% | 2214 |
|
|
2020
Q2 | $17K | Sell |
2,165
-1,311
| -38% | -$10K | ﹤0.01% | 2173 |
|
|
2020
Q1 | $21K | Sell |
3,476
-93,468
| -96% | -$823K | ﹤0.01% | 2040 |
|
|
2019
Q4 | $1.18M | Sell |
96,944
-76,743
| -44% | -$839K | 0.01% | 993 |
|
|
2019
Q3 | $2.01M | Sell |
173,687
-155,963
| -47% | -$1.64M | 0.01% | 748 |
|
|
2019
Q2 | $3.29M | Sell |
329,650
-59,367
| -15% | -$640K | 0.01% | 633 |
|
|
2019
Q1 | $5.01M | Buy |
389,017
+78,884
| +25% | +$1.17M | 0.02% | 510 |
|
|
2018
Q4 | $4.71M | Buy |
310,133
+89,975
| +41% | +$1.71M | 0.02% | 479 |
|
|
2018
Q3 | $4.4M | Buy |
220,158
+21,748
| +11% | +$495K | 0.02% | 559 |
|
|
2018
Q2 | $3.87M | Sell |
198,410
-163,842
| -45% | -$3.62M | 0.02% | 624 |
|
|
2018
Q1 | $7.3M | Buy |
362,252
+56,211
| +18% | +$951K | 0.03% | 431 |
|
|
2017
Q4 | $4.05M | Buy |
306,041
+85,116
| +39% | +$1.28M | 0.02% | 613 |
|
|
2017
Q3 | $4.08M | Buy |
220,925
+43,193
| +24% | +$805K | 0.02% | 631 |
|
|
2017
Q2 | $3.27M | Buy |
177,732
+27,335
| +18% | +$542K | 0.01% | 700 |
|
|
2017
Q1 | $3.39M | Buy |
150,397
+140,731
| +1,456% | +$3.37M | 0.01% | 698 |
|
|
2016
Q4 | $336K | Sell |
9,666
-13,666
| -59% | -$408K | ﹤0.01% | 1582 |
|
|
2016
Q3 | $572K | Buy |
23,332
+20,023
| +605% | +$500K | ﹤0.01% | 1398 |
|
|
2016
Q2 | $79K | Sell |
3,309
-2,579
| -44% | -$59.1K | ﹤0.01% | 1969 |
|
|
2016
Q1 | $138K | Buy |
5,888
+2,579
| +78% | +$61.2K | ﹤0.01% | 1773 |
|
|
2015
Q4 | $100K | Sell |
3,309
-831
| -20% | -$26.8K | ﹤0.01% | 1800 |
|
|
2015
Q3 | $164K | Buy |
4,140
+3,730
| +910% | +$232K | ﹤0.01% | 1664 |
|
|
2015
Q2 | $28K | Buy |
+410
| New | +$25.8K | ﹤0.01% | 2253 |
|
|
2014
Q4 | – | Sell |
-9,414
| Closed | -$300K | – | 2373 |
|
|
2014
Q3 | $300K | Hold |
9,414
| – | – | ﹤0.01% | 1481 |
|
|
2014
Q2 | $195K | Sell |
9,414
-352
| -4% | -$6.5K | ﹤0.01% | 1725 |
|
|
2014
Q1 | $189K | Buy |
+9,766
| New | +$207K | ﹤0.01% | 1764 |
|
|
2013
Q3 | – | Sell |
-10,428
| Closed | -$232K | – | 2391 |
|
|
2013
Q2 | $232K | Buy |
+10,428
| New | +$230K | ﹤0.01% | 1557 |
|
Panagora Asset Management's AMAG Position: Q4 2020 in Review
Panagora Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 2,165 shares — an estimated $20K sold.
Panagora Asset Management first reported a position in AMAG in Q2 2013 and held it in 26 quarters. The position peaked at $7.3M in Q1 2018. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Panagora Asset Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Panagora Asset Management sold 2,165 AMAG Pharmaceuticals shares in Q4 2020, an estimated $20K.
- Panagora Asset Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 26 quarters.
- Panagora Asset Management's AMAG Pharmaceuticals position peaked at $7.3M in Q1 2018.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.